Pharmaceutical industry – Page 60
-
Opinion
Difficult diseases to drug
Derek Lowe wonders why some diseases are easier to drug than others
-
Opinion
Beautiful chemistry
Derek Lowe considers what makes a good looking drug molecule - and how beauty is in the eye of the beholder
-
Opinion
Formulation chemist friction
Derek Lowe wonders where we'd be without the formulation chemists
-
Opinion
Collaborative compromise
Derek Lowe wonders about pharmaceutical companies' motives for collaboration
-
Opinion
Prescription unknowns
Derek Lowe considers what we think we know about how drugs work once we've taken them
-
NewsHeteroaromatic rings of the future
A new computer program compiles library of untapped aromatic heterocycles
-
Opinion
Stick to the steps
Derek Lowe considers the problems of addressing drug development out of sequence
-
Opinion
A new wave of consolidation
Derek Lowe worries that mergers are upsetting the balance of the pharmaceutical ecosystem
-
Opinion
Cutting-edge technology for cutting-edge results?
How important is it to have the best equipped lab, wonders Derek Lowe
-
Feature
Something in the water
Drugs have been finding their way into our water supplies for as long as they have been in use, so should we worry? Maria Burke reports
-
Opinion
A means to an end
Derek Lowe remembers leaving the ivory towers of academe to trade 'unusual and beautiful' for 'useful'
-
Opinion
Reaction variety – the spice of life?
Derek Lowe is looking for a little more variety among his reactions
-
Opinion
Divided by a common language
Derek Lowe dreams of the day when chemists and biologists can understand each other
-
Opinion
A dose of realism
The recent row over antidepressants reminds us how little we know about the brain, says Derek Lowe